Patents by Inventor Jo-Anne Hongo

Jo-Anne Hongo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER
    Publication number: 20070264267
    Abstract: The present invention concerns compositions and methods for the treatment of disorders characterized by the overexpression of an LIV-1. More specifically, the compositions include DNA and amino acid sequences of an LIV-1, antibodies to an LIV-1, and methods for the treatment of a mammal susceptible to or diagnosed with cancer wherein an LIV-1 is overexpressed.
    Type: Application
    Filed: October 5, 2006
    Publication date: November 15, 2007
    Applicant: Genentech, Inc.
    Inventors: Frederic de Sauvage, Audrey Goddard, Austin Gurney, Jo-Anne Hongo, Victoria Smith
  • COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR OF HEMATOPOIETIC ORIGIN
    Publication number: 20070207142
    Abstract: The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.
    Type: Application
    Filed: August 3, 2006
    Publication date: September 6, 2007
    Applicant: Genentech, Inc.
    Inventors: Craig Crowley, Frederic de Sauvage, Dan Eaton, Allen Ebens, Jo-Anne Hongo, Andrew Polson, Sarajane Ross, Victoria Smith, Richard Vandlen
  • Agonist anti-trk-C monoclonal antibodies
    Publication number: 20070036794
    Abstract: The invention concerns agonist anti-trkC monoclonal antibodies which mimic certain biological activities of NT-3, the native ligand of trkC. The invention further concerns the use of such antibodies in the prevention and/or treatment of cellular degeneration, including nerve cell damage associated with acute nervous cell system injury and chronic neurodegenerative diseases, including peripheral neuropathy.
    Type: Application
    Filed: October 16, 2006
    Publication date: February 15, 2007
    Inventors: Brigitte Devaux, Jo-Anne Hongo, Leonard Presta, David Shelton
  • Compositions and methods for modulating vascular development
    Publication number: 20070031437
    Abstract: The present invention provides methods of using EGFL7 antagonist to modulate vascular development. Also provided herein are methods of screening for modulators of EGFL7 activity. Furthermore, methods of treatment using EGFL7 antagonists are provided.
    Type: Application
    Filed: October 12, 2006
    Publication date: February 8, 2007
    Applicant: Genentech, Inc.
    Inventors: Ellen Filvaroff, Weilan Ye, Leon Parker, Jo-Anne Hongo, Maike Schmidt
  • Compositions and methods for the treatment of tumor of hematopoietic origin
    Publication number: 20060251662
    Abstract: The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.
    Type: Application
    Filed: May 4, 2006
    Publication date: November 9, 2006
    Inventors: Wesley Chang, Frederic de Sauvage, Dan Eaton, Allen Ebens, Gretchen Frantz, Jo-Anne Hongo, Hartmut Koeppen, Andrew Polson, Victoria Smith
  • Compositions and methods for the treatment of tumor of hematopoietic origin
    Publication number: 20050226869
    Abstract: The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.
    Type: Application
    Filed: December 21, 2004
    Publication date: October 13, 2005
    Inventors: Wesley Chang, Dan Eaton, Allen Ebens, Frederic de Sauvage, Gretchen Frantz, Jo-Anne Hongo, Hartmut Koeppen, Andrew Polson, Victoria Smith
  • Methods and compositions for selective modulation of vascularization
    Publication number: 20050026829
    Abstract: The invention provides methods and compositions for modulating vascularization and angiogenesis, including selective modulation of stages of multi-step vascularization and angiogenesis.
    Type: Application
    Filed: April 14, 2004
    Publication date: February 3, 2005
    Inventors: Mary Gerritsen, Jo-Anne Hongo, Constance Zlot
  • Agonist anti-trk-c monoclonal antibodies
    Publication number: 20040137513
    Abstract: The invention concerns agonist anti-trkC monoclonal antoibodies which mimic certain biological activities of NT-3, the native ligand of trkC. The invention further concerns the use of such antibodies in the prevention and/or treatment of cellular degeneration, including nerve cell damage associated with acute nervous cell system injury and chronic neurodegenerative diseases, including peripheral neuropathy.
    Type: Application
    Filed: October 30, 2003
    Publication date: July 15, 2004
    Inventors: Brigitte Devaux, David L. Shelton, Jo-Anne Hongo, Leonard G. Presta